4.6 Article

Smoking Behavior among US Adults with Diabetes or Impaired Fasting Glucose

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 126, Issue 6, Pages 541-U117

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2012.11.029

Keywords

Diabetes; Impaired fasting glucose; Smoking

Funding

  1. Swiss National Science Foundation [PBLAP3-127728/1]
  2. SICPA foundation
  3. National Heart Lung and Blood Institute [K24-HL04440]
  4. National Institute of Diabetes and Digestive Kidney Disease [K24 DK080140]
  5. Pfizer
  6. Nabi Biopharmaceuticals
  7. Swiss National Science Foundation (SNF) [PBLAP3-127728] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

BACKGROUND: Cigarette smoking is a well-known cardiovascular risk factor and its impact on cardiovascular disease is even greater among people with diabetes. The aim of this study is to compare the prevalence and determinants of smoking among US adults with diabetes or impaired fasting glucose, and those without diabetes or impaired fasting glucose. METHODS: Weanalyzed data from the National Health and Nutrition Examination Surveys (1999-2008). Age-adjusted prevalence of smoking was calculated, and we used logistic regression models to identify the correlates of smoking among people with diabetes, impaired fasting glucose, and normal glucose metabolism. RESULTS: Among 24,649 participants >= 20 years old, age-adjusted smoking prevalence was 25.7% in 3111 individuals with diabetes, 24.2% in 3557 individuals with impaired fasting glucose, and 24.1% in 17,981 individuals without diabetes. Smoking prevalence did not differ across groups or change over time (1999-2008) in any group. Younger age, less education, more alcohol consumption, less physical activity, and major depression symptoms were associated with smoking in people with diabetes, impaired fasting glucose, and normal glucose metabolism. CONCLUSIONS: In the US, smoking prevalence among people with diabetes and impaired fasting glucose has not changed and is comparable with the nondiabetic population. Tobacco control efforts should be intensified among this population at high risk for complications and mortality. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available